ZEYNEP NUR: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ZEYNEP NUR
Largest movements
- Stocks and contracts +€3,521
up €3,521 (+403%), from €874 to €4,395
- Cash -€2,578
down €2,578 (-7.8%), from €33,132 to €30,554
mainly Stocks and contracts (-€3,521) and Receivables within one year (-€975)
- Receivables within one year +€975
new in 2025: €975
- Trade debts +€2,572
up €2,572 (+78.9%), from €3,261 to €5,833
- Tax, wage and social debts -€729
down €729 (-15.7%), from €4,630 to €3,901
- Gross operating margin -€11,184
down €11,184 (-69.4%), from €16,109 to €4,925
- Taxes -€2,326
down €2,326 (-79.1%), from €2,941 to €615
- Depreciation -€2,135
no longer reported in 2025 (was €2,135)
- Other operating charges +€1,330
up €1,330 (+92.3%), from €1,441 to €2,770
- Financial charges +€899
up €899 (+159%), from €565 to €1,464
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €34,505 | €36,424 | +€1,918 | +5.6% |
| Fixed assets | 21/28 | €500 | €500 | = | 0.0% |
| Financial fixed assets | 28 | €500 | €500 | = | 0.0% |
| Current assets | 29/58 | €34,005 | €35,924 | +€1,918 | +5.6% |
| Stocks and contracts in progress | 3 | €874 | €4,395 | +€3,521 | +403% |
| Stocks | 30/36 | €874 | €4,395 | +€3,521 | +403% |
| Amounts receivable within one year | 40/41 | - | €975 | +€975 | |
| Other amounts receivable | 41 | - | €975 | +€975 | |
| Cash at bank and in hand | 54/58 | €33,132 | €30,554 | -€2,578 | -7.8% |
| Total equity and liabilities | 10/49 | €34,505 | €36,424 | +€1,918 | +5.6% |
| Equity | 10/15 | €26,614 | €26,690 | +€75 | +0.3% |
| Contributions | 10/11 | €13,510 | €13,510 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11,244 | €11,320 | +€75 | +0.7% |
| Amounts payable | 17/49 | €7,891 | €9,734 | +€1,843 | +23.4% |
| Amounts payable within one year | 42/48 | €7,891 | €9,734 | +€1,843 | +23.4% |
| Trade debts | 44 | €3,261 | €5,833 | +€2,572 | +78.9% |
| Suppliers | 440/4 | €3,261 | €5,833 | +€2,572 | +78.9% |
| Taxes, remuneration and social security | 45 | €4,630 | €3,901 | -€729 | -15.7% |
| Taxes | 450/3 | €4,630 | €3,901 | -€729 | -15.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,135 | - | -€2,135 | |
| Other operating charges | 640/8 | €1,441 | €2,770 | +€1,330 | +92.3% |
| Gross operating margin | 9900 | €16,109 | €4,925 | -€11,184 | -69.4% |
| Operating profit (loss) | 9901 | €12,533 | €2,155 | -€10,378 | -82.8% |
| Financial charges | 65/66B | €565 | €1,464 | +€899 | +159% |
| Recurring financial charges | 65 | €565 | €1,464 | +€899 | +159% |
| Profit (loss) for the period before taxes | 9903 | €11,968 | €691 | -€11,277 | -94.2% |
| Income taxes | 67/77 | €2,941 | €615 | -€2,326 | -79.1% |
| Profit (loss) for the period | 9904 | €9,026 | €75 | -€8,951 | -99.2% |
| Profit (loss) for the period to be appropriated | 9905 | €9,026 | €75 | -€8,951 | -99.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.